Serum N -Acetyl-β- d -Glucosaminidase Activity in Predicting the Development of Hypertension
- 1 June 1995
- journal article
- research article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 25 (6) , 1311-1314
- https://doi.org/10.1161/01.hyp.25.6.1311
Abstract
We conducted a prospective study in residents of a small farming community in southwestern Japan to determine whether elevated serum N -acetyl-β- d -glucosaminidase (NAG) activity would predict future hypertension. The 505 normotensive subjects (blood pressure, P <.002), the sum of skinfolds ( P <.001), baseline blood pressure ( P <.0001), serum cholesterol ( P <.01), serum uric acid level ( P <.0001), and serum NAG activity ( P <.005). Elevated NAG activity showed an independent relationship to future hypertension ( P <.005) after adjustments for age, sex, baseline blood pressure (systolic, diastolic, or mean), uric acid level, and the sum of skinfolds. Therefore, elevated serum NAG activity was an effective indicator of future hypertension, and it might therefore be related to functional and/or structural changes in the cardiovascular system.Keywords
This publication has 4 references indexed in Scilit:
- PRECURSORS OF ESSENTIAL HYPERTENSION: PULMONARY FUNCTION, HEART RATE, URIC ACID, SERUM CHOLESTEROL, AND OTHER SERUM CHEMISTRIESAmerican Journal of Epidemiology, 1990
- Urinary N-acetyl- beta-D-glucosaminidase activities in patients with renal disease.BMJ, 1975
- Increased serum activity of beta-n-acetyl-glucoseaminidase in atherosclerosisThe Lancet Healthy Longevity, 1974
- The Relation of Adiposity to Blood Pressure and Development of HypertensionAnnals of Internal Medicine, 1967